Article
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans
2022-09-22
Abstract excerpt
The primary two-dose SARS-CoV-2 mRNA vaccine series are strongly immunogenic in humans, but the emergence of highly infectious variants necessitated additional doses of these vaccines and the development of new variant-derived ones 1–4 . SARS-CoV-2 booster immunizations in humans primarily recruit pre-existing memory B cells (MBCs) 5–9 . It remains unclear, however, whether the additional doses induce germinal c...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c36ff495-27a2-5197-9280-c0c92e2dbcc1
- DOI
- 10.1101/2022.09.22.509040
